Yang JC - Search Results

1

Treatment of Helicobacter pylori infection: current status and future concepts.

Yang JC, Lu CW, Lin CJ. Yang JC, et al. World J Gastroenterol. 2014 May 14;20(18):5283-93. doi: 10.3748/wjg.v20.i18.5283. World J Gastroenterol. 2014. PMID: 24833858 Free PMC article. Review.

2

Association of metronidazole resistance and natural competence in Helicobacter pylori.

Yeh YC, Chang KC, Yang JC, Fang CT, Wang JT. Yeh YC, et al. Among authors: yang jc. Antimicrob Agents Chemother. 2002 May;46(5):1564-7. doi: 10.1128/AAC.46.5.1564-1567.2002. Antimicrob Agents Chemother. 2002. PMID: 11959600 Free PMC article.

3

Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizers.

Lin CJ, Yang JC, Uang YS, Chern HD, Wang TH. Lin CJ, et al. Among authors: yang jc. Pharmacotherapy. 2003 Jun;23(6):711-9. doi: 10.1592/phco.23.6.711.32177. Pharmacotherapy. 2003. PMID: 12820812

4

Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers.

Lai YC, Yang JC, Huang SH. Lai YC, et al. Among authors: yang jc. World J Gastroenterol. 2004 Apr 1;10(7):991-4. doi: 10.3748/wjg.v10.i7.991. World J Gastroenterol. 2004. PMID: 15052680 Free PMC article. Clinical Trial.

5

Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cells.

Wu YY, Tsai HF, Lin WC, Chou AH, Chen HT, Yang JC, Hsu PI, Hsu PN. Wu YY, et al. Among authors: yang jc. World J Gastroenterol. 2004 Aug 15;10(16):2334-9. doi: 10.3748/wjg.v10.i16.2334. World J Gastroenterol. 2004. PMID: 15285015 Free PMC article.

6

Helicobacter pylori infection and CagA protein translocation in human primary gastric epithelial cell culture.

Lai YP, Yang JC, Lin TZ, Lin JT, Wang JT. Lai YP, et al. Among authors: yang jc. Helicobacter. 2006 Oct;11(5):451-9. doi: 10.1111/j.1523-5378.2006.00438.x. Helicobacter. 2006. PMID: 16961808

7

Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice.

Yang JC, Shun CT, Chien CT, Wang TH. Yang JC, et al. J Nutr. 2008 Nov;138(11):2084-90. doi: 10.3945/jn.108.090985. J Nutr. 2008. PMID: 18936202

8

A new approach for the prevention and treatment of Helicobacter pylori infection via upregulation of autophagy and downregulation of apoptosis.

Yang JC, Chien CT. Yang JC, et al. Autophagy. 2009 Apr;5(3):413-4. doi: 10.4161/auto.5.3.7826. Epub 2009 Apr 13. Autophagy. 2009. PMID: 19197143

9

Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori.

Yang JC, Yang YF, Uang YS, Lin CJ, Wang TH. Yang JC, et al. Among authors: yang yf. Br J Clin Pharmacol. 2009 May;67(5):503-10. doi: 10.1111/j.1365-2125.2009.03393.x. Epub 2009 Feb 23. Br J Clin Pharmacol. 2009. PMID: 19552744 Free PMC article. Clinical Trial.

10

CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection.

Yang JC, Lin CJ. Yang JC, et al. Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):29-41. doi: 10.1517/17425250903386251. Expert Opin Drug Metab Toxicol. 2010. PMID: 19968574 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,774 results

Search Page

Filters